(Tromsø 14. November 2018) Rolf E. Engstad, CSO of Biotec BetaGlucans has today
purchased 100 000 shares in Biotec Pharmacon at NOK 4.24 per share. After this
transaction holds Engstad 550.774 shares and 40.000 options in Biotec Pharmacon
For further information, please contact

Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no